1. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro
2. Approval of Cipro® for use after exposure to inhalational anthrax, Food and Drug Administration, US Department of Health and Human Services Public Health Service 5600, Fishers Lane Rockville, MD 20857, 2000.
3. L.L. Shen, in: D.C. Hoope, J.S. Wolfson (Eds.), Quinolone Antibacterial Agents, American Society for Microbiology, Washington, 1993, p. 77.